Where is ReShape headquartered?

ReShape is located in San Clemente, CA.

Who invested in ReShape?

ReShape has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ReShape?

ReShape closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

reshapelifesciences.com

ReShape

ReShape is a California-based company that designs and manufactures minimally invasive medical devices for the treatment of obesity and metabolic diseases.

Business Model:

Revenue: $11.3M

Employees: 11-50

ReShape was acquired by EnteroMedics.
The acquisition happend on 2017-10-03.
Details of the transaction were not public

Acquirer

EnteroMedics

General Information

Geographic Data

Address: 1001 Calle Amanecer

City: San Clemente

State: CA

Zip: 92673

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$46M

Raised Total:

$138M

Social

Facebook

Twitter

Crunchbase

Metrics

4,599,597Website Global Rank

2,000Website Monthly Traffic

Twitter Followers

Description

ReShape is a California-based company that designs and manufactures minimally invasive medical devices for the treatment of obesity and metabolic diseases.

Contact Phone:
+18449377374

Contact Email:

IPO Details

ReShape went public on 10/3/2007 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/3/2007

Ticker Symbol:
RSLS

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2007	Series A	2	$3M	SV Health Investors New Leaf Venture Partners SV Health Investors New Leaf Venture Partners
2/2009	Post-IPO Equity	3	$20M	U.S. Venture Partners SV Health Investors New Leaf Venture Partners U.S. Venture Partners SV Health Investors New Leaf Venture Partners
6/2021	Post-IPO Equity		$46M
7/2014	Post-IPO Debt		$4M
9/2019	Post-IPO Equity		$15.3M
6/2018	Post-IPO Equity		$1.5M
7/2018	Post-IPO Equity		$3M
2/2015	Post-IPO Debt		$6.8M
6/2012	Post-IPO Equity		$1.5M
10/2012	Post-IPO Equity	4	$15M	Venture Investors SV Health Investors Venture Investors U.S. Venture Partners New Leaf Venture Partners Venture Investors SV Health Investors Venture Investors
2/2023	Post-IPO Equity		$10.2M
4/2015	Post-IPO Debt	2	$12M	Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank
4/2018	Post-IPO Equity		$6M
8/2015	Post-IPO Equity	6	$38M	U.S. Venture Partners HealthCor Partners New Leaf Venture Partners Venture Investors SV Health Investors Endeavour Vision HealthCor Partners U.S. Venture Partners HealthCor Partners New Leaf Venture Partners Venture Investors SV Health Investors Endeavour Vision HealthCor Partners
6/2018	Unattributed		$1.5M
7/2018	Unattributed		$2.8M
4/2020	Debt		$350k	U.S. Small Business Administration.
6/2019	Private Placement		$8M

Acquisitions

Announced Date	Name	Price
1/2021	Obalon Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details